Monograph

General Information

Subsidy Information and Financing Scheme

MAF

Sevelamer Carbonate Tablet 800 mg

Treatment of hyperphosphataemia in patients with chronic kidney disease who have persistent hyperph...

MAFSevelamer Carbonate Tablet 800 mg

Treatment of hyperphosphataemia in patients with chronic kidney disease who have persistent hyperphosphataemia despite optimising treatment with calcium-based phosphate binders, or who are unable to tolerate calcium-based phosphate binders due to hypercalcaemia.

Drug Guidance for Subsidy

01/10/2018 Lanthanum carbonate and sevelamer carbonate for treating hyperphosphataemia in patients with chronic kidney disease

The Ministry of Health’s Drug Advisory Committee has recommended:

Sevelamer carbonate 800 mg...

01/10/2018 Lanthanum carbonate and sevelamer carbonate for treating hyperphosphataemia in patients with chronic kidney disease

The Ministry of Health’s Drug Advisory Committee has recommended:

Sevelamer carbonate 800 mg tablet for the treatment of hyperphosphataemia in patients with chronic kidney disease who:
- have persistent hyperphosphataemia despite optimising treatment with calcium-based phosphate binders; or
- cannot tolerate calcium-based phosphate binders due to hypercalcaemia.

Subsidy status

Sevelamer carbonate 800 mg tablet is recommended for inclusion on the Medication Assistance Fund (MAF) for the abovementioned indication.

MAF assistance does not apply to lanthanum carbonate 500 mg, 750 mg, and 1000 mg tablets.

General Availability in Public Healthcare Institution
Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration

Tablet 800 mg
Alexandra Hospital
Changi General Hospital
Khoo Teck Puat Hospital
Ng Teng Fong General Hospital
National University Hospital
Sengkang General Hospital
Singapore General Hospital
Tan Tock Seng Hospital
Woodlands Health Campus

Registered Product(s) Information

ORAL

Select a brand starting with the letter:

C R S

CAVSAMIR FILM COATED TABLET 800MG [SIN16993P]

RENVELA ® TABLET 800MG [SIN13725P]

SEVELA FILM COATED TABLET 800MG [SIN16105P]

Clinical Info
Product Info

Please select a product for clinical info:

CAVSAMIR FILM COATED TABLET 800MG [SIN16993P]
RENVELA ® TABLET 800MG [SIN13725P]
SEVELA FILM COATED TABLET 800MG [SIN16105P]

Please select a Registered Product for product info.